Discuss This Drug

reteplase

CHEBI:CHEBI_754710

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

dosage_form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
product_type
DRUG FOR FURTHER PROCESSING
marketing_category
DRUG FOR FURTHER PROCESSING
marketing_start_date
19961030
package_marketing_start_date
30-OCT-96
labeler_name
Patheon Italia S.p.A.
generic_name
reteplase
product_ndc
68225-124
spl_id
2617b117-9915-10f4-e063-6294a90a29b3
active_ingredient_name
RETEPLASE
active_ingredient_strength
1.81 mg/mL
package_ndc
68225-124-00
package_description
147 VIAL, SINGLE-USE in 1 BOX (68225-124-00) / 10 mL in 1 VIAL, SINGLE-USE
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class